As of January 2023, the X-waiver is no longer required to prescribe buprenorphine for opioid use disorder. Any references to the X-waiver no longer apply. The educational content on this site that offers CME meets the MATE Act requirements of 8 hours of training required for DEA certification.

The Opioid and Stimulant Implementation Support-Training and Technical Assistance program (OASIS-TTA) at UCLA Integrated Substance Abuse Programs (ISAP) is a state-funded program supported by the Substance Abuse and Mental Health Services Administration (SAMHSA) State Opioid Response SOR3 Grant to the California Department of Health Care Services (DHCS). It consists of three major Training and Technical assistance projects:

  1. Provider Support Initiative (PSI)
  2. CA Hub and Spoke System Implementation Support (CA H&S)
  3. Tribal Trainings

Training content promotes best practices in specialty and primary care settings to enhance the delivery of medications for addiction treatment (MAT) and promote MAT sustainability. Under the expanded OASIS-TTA program, content will address stimulants (methamphetamine and cocaine) and fentanyl and include an emphasis to improve care for vulnerable priority populations (including but not limited to youth, American Indian/Alaska Native populations, and persons experiencing homelessness).

The OASIS-TTA program incorporates multiple targeted implementation support activities:

  • Develop and conduct a statewide survey using quantitative and qualitative methods among MAT prescribers and Tribal MAT providers to determine training/technical assistance needs;
  • Build the appropriate training/TA team and develop curricula addressing targeted areas of support/mentorship needs;
  • Provide distance and/or face-to-face training and technical assistance to increase prescriber/provider skills in delivering MAT services.
  • Provide implementation support to provider programs participating in the CA Hub and Spoke System project through regionalized Learning Collaboratives and ongoing training and mentorship opportunities.
  • Provide training and technical assistance via the Project ECHO™ web-based case consultation mechanism (Tribal MAT ECHO Clinic - for tribal communities, and MAT ECHO Clinic - for general providers).
  • Provide quarterly trainings to rural and urban Indian health care providers to improve treatment programming and services that address the needs of American Indian and Alaska Native (AI/AN) individuals with opioid use disorder, stimulant use disorder, and co-occurring use disorders.

Learn more about Other UCLA Projects addressing OUD and other substance use disorder here.

(Read more...)

UCLA Project Team

Thomas Freese, PhD

Thomas Freese, PhD

Principal Investigator

310-267-5397

tfreese@mednet.ucla.edu

Beth Rutkowski, MPH

Beth Rutkowski, MPH

Director of Training

310-388-7647

brutkowski@mednet.ucla.edu

Valerie P. Antonini, MPH

Valerie P. Antonini, MPH

Project Director

310-267-5306

vpearce@mednet.ucla.edu

Gloria M. Miele, PhD

Gloria M. Miele, PhD

Program Director

310-267-5888

gmiele@mednet.ucla.edu

Christian P Frable, BS

Christian P Frable, MA

Project Coordinator

310-794-8127

cfrable@mednet.ucla.edu

Brandy Oeser

Brandy Oeser, MPH

Project Director

310-267-5331

BOeser@mednet.ucla.edu

Contact the H&S Administrative Support Team